Shots:

• NAMRU-3 to conduct surveillance & clinical validation research while Sorrento will provide technical expertise & access to its portfolio of products to combat SARS-CoV-2 and threats emerging due to variants of concern
• The goal of cooperation is to conduct research on infectious diseases- enhance force health protection & provide data regarding countermeasures to mitigate infectious disease transmission include surveillance & product development
• The collaboration will initially focus on improving infectious disease readiness through surveillance & clinical diagnostic validation activities for COVISTIX/COVITRACK diagnostics & COVIDROPS/COVI-AMG outpatient neutralizing Abs treatment

  | Ref: Globe Newswire | Image: Newsmax